The Thoracic Absorption Dose and Secondary Tumor Risk Caused by Different Imaging Methods in Image‐Guided Particle Radiotherapy

ABSTRACT Background Image‐guided radiation therapy uses imaging methods such as CBCT to effectively improve treatment precision. Kilovoltage‐imaging technology provides high soft tissue contrast at low doses, whereas megavoltage‐imaging technology better displays deep and bony structures at high dos...

Full description

Saved in:
Bibliographic Details
Main Authors: Qinghao Cui, Xianrui Yan, Chengqiang Li, Jian Zhu, Jun Ma, Tingting Liu
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.70102
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849424894179147776
author Qinghao Cui
Xianrui Yan
Chengqiang Li
Jian Zhu
Jun Ma
Tingting Liu
author_facet Qinghao Cui
Xianrui Yan
Chengqiang Li
Jian Zhu
Jun Ma
Tingting Liu
author_sort Qinghao Cui
collection DOAJ
description ABSTRACT Background Image‐guided radiation therapy uses imaging methods such as CBCT to effectively improve treatment precision. Kilovoltage‐imaging technology provides high soft tissue contrast at low doses, whereas megavoltage‐imaging technology better displays deep and bony structures at high doses. Proton therapy is more sensitive to tissue density and positional accuracy, so it requires more stringent image guidance and higher precision than traditional X‐ray therapy. Objective This study evaluates radiation doses from CBCT systems (TrueBeam, Halcyon, ProBeam, TOMO) in both adult and pediatric phantoms, measuring dose variations and predicting secondary tumor risks using a radiobiological model. Methods Absorbed doses in organs of adult and pediatric phantoms were measured with OSLDs across imaging systems. The risk of secondary tumors was estimated using the BEIR VII model. Results Halcyon 2.0 and TOMO's MV‐level imaging systems showed significantly higher doses than KV‐level systems. Pediatric patients received 2–3 times higher doses than adults. In KV‐level imaging, Halcyon 2.0 resulted in the highest lung tissue dose in both age groups (17.464 mGy for pediatric, 9.109 mGy for adult), whereas ProBeam had the lowest (6.844 and 4.073 mGy, respectively). The lifetime attributable risk for lung cancer correlated with the dose, with higher risks in children. Conclusions Higher radiation doses lead to greater secondary tumor risk, with the risk being more pronounced in pediatric patients. Continuous thoracic CBCT can deliver up to 1 Gy in thoracic organs, posing a significant risk of secondary tumors, especially in younger patients. Careful consideration of this risk is essential in treatment planning.
format Article
id doaj-art-4b63172c6cff4e51b63949d2a3206775
institution Kabale University
issn 1759-7706
1759-7714
language English
publishDate 2025-06-01
publisher Wiley
record_format Article
series Thoracic Cancer
spelling doaj-art-4b63172c6cff4e51b63949d2a32067752025-08-20T03:29:58ZengWileyThoracic Cancer1759-77061759-77142025-06-011612n/an/a10.1111/1759-7714.70102The Thoracic Absorption Dose and Secondary Tumor Risk Caused by Different Imaging Methods in Image‐Guided Particle RadiotherapyQinghao Cui0Xianrui Yan1Chengqiang Li2Jian Zhu3Jun Ma4Tingting Liu5Linyi Hospital of Traditional Chinese Medicine Department of Radiation Oncology Physics & Technology Linyi ChinaLaboratory of Image Science and Technology, Jiangsu Provincial Joint International Research Laboratory of Medical Information Processing, Centre de Recherche en Information Biomédicale Sino‐français (CRIBs) Southeast University Nanjing People's Republic of ChinaShandong Provincial Key Medical and Health Laboratory of Pediatric Cancer Precision Radiotherapy Shandong Cancer Hospital Jinan ChinaShandong Provincial Key Medical and Health Laboratory of Pediatric Cancer Precision Radiotherapy Shandong Cancer Hospital Jinan ChinaCancer Hospital of Shandong First Medical University Jinan ChinaSun Yat‐Sen University Cancer Center Gansu Hospital Lanzhou ChinaABSTRACT Background Image‐guided radiation therapy uses imaging methods such as CBCT to effectively improve treatment precision. Kilovoltage‐imaging technology provides high soft tissue contrast at low doses, whereas megavoltage‐imaging technology better displays deep and bony structures at high doses. Proton therapy is more sensitive to tissue density and positional accuracy, so it requires more stringent image guidance and higher precision than traditional X‐ray therapy. Objective This study evaluates radiation doses from CBCT systems (TrueBeam, Halcyon, ProBeam, TOMO) in both adult and pediatric phantoms, measuring dose variations and predicting secondary tumor risks using a radiobiological model. Methods Absorbed doses in organs of adult and pediatric phantoms were measured with OSLDs across imaging systems. The risk of secondary tumors was estimated using the BEIR VII model. Results Halcyon 2.0 and TOMO's MV‐level imaging systems showed significantly higher doses than KV‐level systems. Pediatric patients received 2–3 times higher doses than adults. In KV‐level imaging, Halcyon 2.0 resulted in the highest lung tissue dose in both age groups (17.464 mGy for pediatric, 9.109 mGy for adult), whereas ProBeam had the lowest (6.844 and 4.073 mGy, respectively). The lifetime attributable risk for lung cancer correlated with the dose, with higher risks in children. Conclusions Higher radiation doses lead to greater secondary tumor risk, with the risk being more pronounced in pediatric patients. Continuous thoracic CBCT can deliver up to 1 Gy in thoracic organs, posing a significant risk of secondary tumors, especially in younger patients. Careful consideration of this risk is essential in treatment planning.https://doi.org/10.1111/1759-7714.70102CBCTLAROSLDparticle radiotherapythoracic dose
spellingShingle Qinghao Cui
Xianrui Yan
Chengqiang Li
Jian Zhu
Jun Ma
Tingting Liu
The Thoracic Absorption Dose and Secondary Tumor Risk Caused by Different Imaging Methods in Image‐Guided Particle Radiotherapy
Thoracic Cancer
CBCT
LAR
OSLD
particle radiotherapy
thoracic dose
title The Thoracic Absorption Dose and Secondary Tumor Risk Caused by Different Imaging Methods in Image‐Guided Particle Radiotherapy
title_full The Thoracic Absorption Dose and Secondary Tumor Risk Caused by Different Imaging Methods in Image‐Guided Particle Radiotherapy
title_fullStr The Thoracic Absorption Dose and Secondary Tumor Risk Caused by Different Imaging Methods in Image‐Guided Particle Radiotherapy
title_full_unstemmed The Thoracic Absorption Dose and Secondary Tumor Risk Caused by Different Imaging Methods in Image‐Guided Particle Radiotherapy
title_short The Thoracic Absorption Dose and Secondary Tumor Risk Caused by Different Imaging Methods in Image‐Guided Particle Radiotherapy
title_sort thoracic absorption dose and secondary tumor risk caused by different imaging methods in image guided particle radiotherapy
topic CBCT
LAR
OSLD
particle radiotherapy
thoracic dose
url https://doi.org/10.1111/1759-7714.70102
work_keys_str_mv AT qinghaocui thethoracicabsorptiondoseandsecondarytumorriskcausedbydifferentimagingmethodsinimageguidedparticleradiotherapy
AT xianruiyan thethoracicabsorptiondoseandsecondarytumorriskcausedbydifferentimagingmethodsinimageguidedparticleradiotherapy
AT chengqiangli thethoracicabsorptiondoseandsecondarytumorriskcausedbydifferentimagingmethodsinimageguidedparticleradiotherapy
AT jianzhu thethoracicabsorptiondoseandsecondarytumorriskcausedbydifferentimagingmethodsinimageguidedparticleradiotherapy
AT junma thethoracicabsorptiondoseandsecondarytumorriskcausedbydifferentimagingmethodsinimageguidedparticleradiotherapy
AT tingtingliu thethoracicabsorptiondoseandsecondarytumorriskcausedbydifferentimagingmethodsinimageguidedparticleradiotherapy
AT qinghaocui thoracicabsorptiondoseandsecondarytumorriskcausedbydifferentimagingmethodsinimageguidedparticleradiotherapy
AT xianruiyan thoracicabsorptiondoseandsecondarytumorriskcausedbydifferentimagingmethodsinimageguidedparticleradiotherapy
AT chengqiangli thoracicabsorptiondoseandsecondarytumorriskcausedbydifferentimagingmethodsinimageguidedparticleradiotherapy
AT jianzhu thoracicabsorptiondoseandsecondarytumorriskcausedbydifferentimagingmethodsinimageguidedparticleradiotherapy
AT junma thoracicabsorptiondoseandsecondarytumorriskcausedbydifferentimagingmethodsinimageguidedparticleradiotherapy
AT tingtingliu thoracicabsorptiondoseandsecondarytumorriskcausedbydifferentimagingmethodsinimageguidedparticleradiotherapy